-
Diagnostics World News | An all-in-one metagenomics test developed by University of California San Francisco (UCSF) scientists could transform the way infectious diseases are diagnosed at the point of care, irrespective of the sample type. The same technology is being adapted as a means to simultaneously detect SARS-CoV-2 and track down drivers of COVID-19 outbreaks at the community level.
Jan 6, 2021
-
Diagnostics World News | Updates from Ibex Medical Analytics and Paige on AI-assisted breast cancer diagnoses, using vocal biomarkers to diagnose pulmonary hypertension, whole genome sequencing in diagnoses, and more.
Jan 4, 2021
-
Diagnostics World News | By March, the whole world was faced with a massive diagnostics problem, and companies everywhere pivoted to focus on methods for diagnosing SARS-CoV-2 infections quickly, accurately, and with a test that could scale. But COVID-19 diagnoses weren’t the year’s only developments. We also covered the growing trends in medical monitoring, organ-on-a-chip models, the regulatory environment for laboratory-developed tests and much more.
Dec 29, 2020
-
Diagnostics World News | Funding updates around the diagnostics industry including cash for glycoproteomic-powered ovarian cancer diagnostics, investments in diagnosing traumatic brain injury, digital pathology, scaled up production of QuantuMDx’s portable PCR diagnostic device, and more.
Dec 21, 2020
-
Diagnostics World News | New five plex RT-qPCR test, novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform, and why temperature screening doesn’t work to diagnose or control COVID-19 spread. Plus: new SARS-CoV-2 antigen ELISA.
Dec 18, 2020
-
Diagnostics World News | There is no question that genetic/genomic testing rapidly is becoming the gold standard of care, across clinical specialties and care settings. Genetic information serves as the patient’s lifelong signature. It can—and should—be referenced and interrogated by providers for years and decades into the future.
Dec 15, 2020
-
Diagnostic World News I Two-thirds of COVID-19 patients lose sense of taste and smell, nanoPCR technology for diagnosis, biomarkers of blood vessel damage in children, sore eyes significant ocular symptom, Nanopore sequencing technology, understanding viral persistence and immune responses, and IgA antibodies dominate early neutralizing response. Plus: New testing method detects gene expression patterns, lung sound recording system prototype, healthcare workers immunity lasts several months, and combining antibody assays may yield most accurate results.
Dec 11, 2020
-
Diagnostics World News | Researchers have been experimenting with abbreviated (aka “fast”) breast MRI for about a decade now and the consensus seems to be that it’s a cost-effective modality for screening women at intermediate risk, including those with dense breast tissue as the sole risk factor.
Dec 10, 2020
-
Diagnostics World News | A group of researchers from IBM and Pfizer has developed an AI model that uses small samples of language to predict the onset of Alzheimer’s disease (AD) in healthy individuals.
Dec 8, 2020